These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Urinary incontinence: what's new in therapy?]. Becher KF; Sieber CC Dtsch Med Wochenschr; 2015 Feb; 140(3):164-7. PubMed ID: 25658400 [No Abstract] [Full Text] [Related]
3. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions. Kuo HC J Urol; 2003 Sep; 170(3):835-9. PubMed ID: 12913711 [TBL] [Abstract][Full Text] [Related]
4. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial. Silva C; Silva J; Ribeiro MJ; Avelino A; Cruz F Eur Urol; 2005 Oct; 48(4):650-5. PubMed ID: 15961217 [TBL] [Abstract][Full Text] [Related]
5. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. Giannantoni A; Di Stasi SM; Stephen RL; Bini V; Costantini E; Porena M J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783 [TBL] [Abstract][Full Text] [Related]
8. Bladder rehabilitation in neurogenic and non-neurogenic detrusor dysfunction with intravesical electrotherapy. Helmut M; Gustav K; Dora M Ideggyogy Sz; 2005 Sep; 58(9-10):329-33. PubMed ID: 16252894 [No Abstract] [Full Text] [Related]
9. Mechanisms of action of intravesical botulinum treatment in refractory detrusor overactivity. Drake MJ BJU Int; 2008 Jul; 102 Suppl 1():11-6. PubMed ID: 18665973 [TBL] [Abstract][Full Text] [Related]
10. Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity. Wyndaele JJ; Van Dromme SA Spinal Cord; 2002 Nov; 40(11):599-600. PubMed ID: 12411968 [No Abstract] [Full Text] [Related]
11. Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist. Santos-Silva A; Charrua A; Cruz CD; Gharat L; Avelino A; Cruz F Auton Neurosci; 2012 Jan; 166(1-2):35-8. PubMed ID: 22037502 [TBL] [Abstract][Full Text] [Related]
12. [Clinical study of resiniferatoxin on neurogenic bladder]. Liu TJ; Zhao MJ; Sha KF; Gao JZ Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(26):1827-9. PubMed ID: 20979828 [TBL] [Abstract][Full Text] [Related]
13. [Intravesical oxybutynin in children with meningomyelocele. Efficient treatment with few side-effects]. Von Zweigbergk M; Nordin B; Jonsson S Lakartidningen; 1996 Oct; 93(41):3573-6. PubMed ID: 8965514 [No Abstract] [Full Text] [Related]
14. Modulation of urinary bladder innervation: TRPV1 and botulinum toxin A. Charrua A; Avelino A; Cruz F Handb Exp Pharmacol; 2011; (202):345-74. PubMed ID: 21290235 [TBL] [Abstract][Full Text] [Related]
15. Event driven electrical stimulation of the dorsal penile/clitoral nerve for management of neurogenic detrusor overactivity in multiple sclerosis. Fjorback MV; Rijkhoff N; Petersen T; Nohr M; Sinkjaer T Neurourol Urodyn; 2006; 25(4):349-55. PubMed ID: 16673380 [TBL] [Abstract][Full Text] [Related]
16. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder. Haferkamp A; Schurch B; Reitz A; Krengel U; Grosse J; Kramer G; Schumacher S; Bastian PJ; Büttner R; Müller SC; Stöhrer M Eur Urol; 2004 Dec; 46(6):784-91. PubMed ID: 15548448 [TBL] [Abstract][Full Text] [Related]